Delivery Order SPE2DB20D3303-SPE2DB25FA1US
Award Date 7/28/25
Potential Completion Date 8/18/25
Potential Value $1.1K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of XEOMIN 200 unit vials, with a ceiling value of $2,234.96 and an ultimate completion date of August 4, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and specifies Conshohocken, Pennsylvania as the place of performance. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $11,174.80 to supply 200-unit vials of XEOMIN on April 24, 2025, with an ultimate completion date of May 15, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) SPE2DX with DLA...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of XEOMIN 100 Unit vials. This firm fixed-price delivery order, valued at $23,467.08, represents a non-competitive set-aside award and is scheduled for completion by August 7, 2025. The contract will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This award is issued as a child order under...
- The Defense Logistics Agency awarded a delivery order valued at $27,937.00 to AmerisourceBergen Drug Corp for the supply of XEOMIN 200 Unit Vials, with a completion date of July 16, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The vendor, headquartered in Conshohocken, Pennsylvania, will perform at its corporate office location. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency (DLA) awarded a $11,174.80 firm fixed price delivery order to AmerisourceBergen Drug Corp for 100-unit vials of Xeomin, a neuromodulator medication commonly used for therapeutic and cosmetic applications. This non-competitive delivery order, issued on July 29, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion through December 2026. The product...
- The Defense Logistics Agency awarded a delivery order valued at $100,573.20 to AmerisourceBergen Drug Corp for the supply of XEOMIN 200 unit vials, with an ultimate completion date of September 4, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement and will be performed at the awardee's corporate headquarters in Conshohocken, Pennsylvania. XEOMIN is a botulinum toxin product used in medical applications, and this order supports the federal...
- The Defense Logistics Agency awarded a delivery order valued at $2,793.70 to AmerisourceBergen Drug Corp for 100-unit vials of XEOMIN, a botulinum toxin product used for therapeutic and cosmetic medical applications. This firm fixed price delivery order, awarded on August 28, 2025, is set to be completed by September 19, 2025, and will be performed at the contractor's Conshohocken, Pennsylvania location. As a non-set-aside competitive award, this delivery order was issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,704.88 to AmerisourceBergen Drug Corp for XEOMIN 100 Unit Vials, with a completion date of September 30, 2025. The contract represents a firm fixed price delivery order with no set-aside designation, competitively awarded on September 9, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform this delivery order from its corporate office location. This award is issued as a child contract under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for XEOMIN 200 Unit Vials valued at $13,409.76 on May 30, 2025, with an ultimate completion date of June 23, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. XEOMIN is a botulinum toxin product used for therapeutic and cosmetic applications, and this procurement...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on August 21, 2025, with a ceiling value of $1,955.59 for the supply of XEOMIN 100 Unit Vials. The contract is a firm fixed-price delivery order with an ultimate completion date of September 12, 2025, and will be performed at the awardee's facility in Conshohocken, Pennsylvania. This award was made through competitive procedures with no set-aside designation and represents a child contract under...